![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Publisher's version)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
626kB |
Preview |
PDF (Supplementary Appendix)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB |
| Item Type: | Letter |
|---|---|
| Title: | Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B cell impairment and increases the risk for infections - a retrospective matched cohort study. |
| Creators Name: | Launspach, M., Temel, D., Ohlendorf, E., Zirngibl, F., Materne, B., Oevermann, L., Deubzer, H.E., Henssen, A.G., Künkele, A., Hundsdörfer, P., von Bernuth, H., Pruß, A., Eggert, A., von Stackelberg, A., Lang, P. and Schulte, J.H. |
| Keywords: | Autologous Transplantation, Cohort Studies, Hematopoietic Stem Cell Transplantation, Retrospective Studies, Risk Factors, Rituximab |
| Source: | Haematologica |
| ISSN: | 0390-6078 |
| Publisher: | Ferrata Storti Foundation |
| Volume: | 108 |
| Number: | 1 |
| Page Range: | 267-272 |
| Date: | January 2023 |
| Official Publication: | https://doi.org/10.3324/haematol.2022.281134 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
